Karuna Therapeutics Inc - Ordinary Shares
The momentum for this stock is not very good. Karuna Therapeutics Inc - Ordinary Shares is not a good growth stock. Karuna Therapeutics Inc - Ordinary Shares is not very popular among insiders. Tradey thinks it is not wise to invest in Karuna Therapeutics Inc - Ordinary Shares.
Log in to see more information.
News
SG Americas Securities LLC Purchases 167,448 Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Ticker Report SG Americas Securities LLC boosted its position in Karuna Therapeutics, Inc. (NASDAQ:KRTX Free Report) by 2,482.6% during the fourth quarter, according to the company in its most recent Form...\n more…
PureTech made millions on Karuna acquisition. Here's what it plans to return to shareholders.
BizJournals.com - Nat'l Business News On Monday, Bristol Myers Squibb completed its acquisition of Boston drug developer Karuna Therapeutics Inc. for $14 billion. Karuna is a spinout of Boston-based PureTech Health, which will receive hundreds of millions of dollars from its stake in Karuna. Here's what it plans to do withe the proceeds.\n more…
